// App-Quantinova.ai

: Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Chronic Lymphocytic Leukaemia (CLL-SHIELD)

Researchers

Presenter

  • Ashley Whitechurch

Principal Investigators

  • Rory Bennett

  • Shafqat Inam

  • Benjamin Hartog

  • Rebecca Blackwood

  • Shevon Fernando

  • Felanita Hutani

  • Hadley Bortz

  • Mitchel Lincoln

  • Dennis Carney

  • Andrew W Roberts

  • Mary Ann Anderson

  • Constantine S. Tam

  • John F. Seymour

Medical Centers

  • The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

  • Blood Cells and Blood Cancers, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

  • Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

  • Royal Melbourne Hospital, Parkville, Australia

  • University of Melbourne, Melbourne, Australia

  • MONASH UNIVERSITY, Melbourne, Australia

  • Alfred Hospital, Melbourne, Australia

  • Peter MacCallum Cancer Centre, MELBOURNE, Australia

  • Peter MacCallum Cancer Centre & Royal Melbourne Hospital, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved